HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M M Samama Selected Research

cancer procoagulant

1/2001The thrombophilic state in cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M M Samama Research Topics

Disease

9Venous Thromboembolism
06/2011 - 07/2000
5Thrombocytopenia (Thrombopenia)
02/2011 - 05/2000
4Hemorrhage
10/2013 - 02/2002
4Thrombosis (Thrombus)
02/2011 - 03/2000
3Atrial Fibrillation
10/2013 - 02/2011
3Venous Thrombosis (Deep-Vein Thrombosis)
11/2005 - 10/2001
3Neoplasms (Cancer)
03/2005 - 11/2000
2Thrombophilia
11/2005 - 06/2002
2Activated Protein C Resistance (APC Resistance)
07/2002 - 01/2001
1Stroke (Strokes)
06/2011
1Acute Coronary Syndrome
02/2011
1von Willebrand Diseases (von Willebrand's Disease)
04/2006
1Congenital Abnormalities (Deformity)
03/2005
1Coronary Thrombosis
11/2002
1Body Weight (Weight, Body)
06/2002
1Postoperative Pain
02/2002
1Acute Kidney Injury (Acute Renal Failure)
02/2002
1Hypersensitivity (Allergy)
02/2002
1Pain (Aches)
02/2002
1Inflammation (Inflammations)
01/2001
1Thrombocytosis (Thrombocythemia)
01/2001
1Heart Failure
12/2000
1Venous Insufficiency
12/2000
1Obesity
12/2000
1Communicable Diseases (Infectious Diseases)
12/2000
1Hematologic Neoplasms (Hematological Malignancy)
12/2000
1Wounds and Injuries (Trauma)
12/2000
1Myocardial Infarction
07/2000

Drug/Important Bio-Agent (IBA)

8AnticoagulantsIBA
10/2013 - 09/2001
5Heparin (Liquaemin)FDA LinkGeneric
02/2011 - 05/2000
3ThrombinFDA Link
10/2013 - 01/2001
2Pharmaceutical PreparationsIBA
10/2013 - 12/2000
2fibrin fragment D (D-dimer)IBA
11/2005 - 12/2003
2Biological ProductsIBA
03/2005 - 11/2000
1Factor IIaIBA
10/2013
1N(4)-oleylcytosine arabinosideIBA
10/2013
1RivaroxabanIBA
10/2013
1DabigatranFDA Link
10/2013
1Factor Xa InhibitorsIBA
10/2013
1edoxabanIBA
06/2011
1Factor Xa (Coagulation Factor Xa)IBA
06/2011
1RistocetinIBA
04/2006
1Factor VIII (Coagulation Factor VIII)IBA
04/2006
1von Willebrand FactorIBA
04/2006
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2005
1Vitamin KFDA Link
03/2005
1Dalteparin (Dalteparin Sodium)FDA Link
03/2005
1Biomarkers (Surrogate Marker)IBA
11/2002
1Protein CIBA
07/2002
1Prothrombin (Factor II)IBA
07/2002
1factor V LeidenIBA
07/2002
1Ketoprofen (Orudis)FDA LinkGeneric
02/2002
1Diclofenac (SR 38)FDA LinkGeneric
02/2002
1KetorolacIBA
02/2002
1AntibodiesIBA
10/2001
1Platelet Factor 4IBA
10/2001
1Thromboplastin (Tissue Factor)IBA
01/2001
1Fibrin Fibrinogen Degradation ProductsIBA
01/2001
1cancer procoagulantIBA
01/2001
1Antiphospholipid AntibodiesIBA
01/2001
1Fibrinopeptide AIBA
01/2001
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2001
1Fibrinogen (Factor I)FDA Link
01/2001
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2001
1AntithrombinsIBA
01/2001
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2000

Therapy/Procedure

2Therapeutics
11/2005 - 07/2000
2Orthopedic Procedures
03/2005 - 11/2004
2Duration of Therapy
06/2002 - 02/2002
1Subcutaneous Injections
06/2002
1Secondary Prevention
10/2001
1Surgical Casts (Plaster Cast)
12/2000
1Operative Surgical Procedures
07/2000